Asia Beat: Chinese pharma regulation really scraping the gutter?
This article was originally published in Scrip
Executive Summary
Renewed territorial claims to disputed islets in the South China Sea have ratcheted up China's profile in an increasingly tense Asia in recent weeks, while in the pharmaceutical field the country has garnered the sort of attention its regulatory authorities could do without.